{
  "docId": "019de511-96cd-7638-a1d6-3e4d5ad533a5",
  "docSlug": "302359bc76c31f98badc01a5486f3d4f",
  "documentTitle": "Thorne HealthTech | IPO Presentation Deck | 45 slides",
  "authorId": "thorne-healthtech",
  "authorName": "Thorne HealthTech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7910448,
  "pageNumber": 43,
  "pageCount": 45,
  "prevPage": 42,
  "nextPage": 44,
  "slideType": "other",
  "function": "illustrate_case",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": "Includes a screenshot of a ClinicalTrials.gov record for the STOP-IPF trial.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de511-96cd-7638-a1d6-3e4d5ad533a5/43",
  "deckHref": "/decks/019de511-96cd-7638-a1d6-3e4d5ad533a5",
  "deckJsonHref": "/decks/019de511-96cd-7638-a1d6-3e4d5ad533a5.json",
  "deckAnchorHref": "/decks/019de511-96cd-7638-a1d6-3e4d5ad533a5#slide-43",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.06,
        "y": 0.36
      },
      "kind": "callout",
      "text": "US FDA grants saracatinib Orphan Drug Designation for IPF",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "01cbf809-ff86-49d3-9294-64d5650d7e2b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "image",
      "text": "ClinicalTrials.gov record for Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis (STOP-IPF)",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "af40df3a-b934-4f5f-8d52-2e861818aab3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.35,
        "x": 0.6,
        "y": 0.25
      },
      "kind": "list",
      "text": "Blinded analysis of 32 unique compounds; Identified saracatinib as modulator of IPF; Demonstrate efficacy in pre-clinical IPF model; Currently undergoing a Phase 1b/2a double-blind, randomized, placebo-controlled, single-dose, three-site trial (NCT04598919)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d4dd0c95-41dc-4054-a716-02b85b5f2a71",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Pharma Case Study: Discovery Pipeline Identifies Saracatinib for Idiopathic Pulmonary Fibrosis (IPF)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "762536e2-19ff-466f-819a-b9eaf7c08194",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}